7.65
price up icon3.38%   0.25
after-market After Hours: 3.43 -4.22 -55.16%
loading
Mimedx Group Inc stock is traded at $7.65, with a volume of 2.79M. It is up +3.38% in the last 24 hours and up +9.60% over the past month. MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$7.40
Open:
$7.35
24h Volume:
2.79M
Relative Volume:
3.77
Market Cap:
$1.13B
Revenue:
$342.81M
Net Income/Loss:
$97.67M
P/E Ratio:
12.45
EPS:
0.6145
Net Cash Flow:
$50.46M
1W Performance:
+13.17%
1M Performance:
+9.60%
6M Performance:
+11.19%
1Y Performance:
+11.68%
1-Day Range:
Value
$7.275
$7.815
1-Week Range:
Value
$6.68
$7.89
52-Week Range:
Value
$5.79
$10.14

Mimedx Group Inc Stock (MDXG) Company Profile

Name
Name
Mimedx Group Inc
Name
Phone
(770) 651-9100
Name
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Name
Employee
837
Name
Twitter
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
MDXG's Discussions on Twitter

Compare MDXG with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
6.49 0 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
3.32 3.71B 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.07 372.90M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
4.40 174.62M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.2615 587.26M 2.07B -1.42B -1.37B -0.6765
 icon
DAVEW
Dave Inc
1.31 0 0 0 0 0.00

Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-02-24 Initiated Cantor Fitzgerald Overweight
Mar-07-24 Initiated Lake Street Buy
Oct-27-23 Initiated Craig Hallum Buy
Oct-13-22 Initiated Mizuho Buy
Jul-26-21 Initiated Northland Capital Outperform
Mar-19-21 Initiated H.C. Wainwright Buy
View All

Mimedx Group Inc Stock (MDXG) Latest News

pulisher
01:29 AM

Cantor Fitzgerald Predicts Higher Earnings for MiMedx Group - MarketBeat

01:29 AM
pulisher
Nov 02, 2025

Is MiMedx Group Inc. stock a safe investment in uncertain marketsWeekly Trend Summary & Daily Growth Stock Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

MiMedx Shares Surge on Strong Earnings and Favorable Regulatory Outlook - AD HOC NEWS

Nov 02, 2025
pulisher
Nov 02, 2025

MiMedx Group (NASDAQ:MDXG) Raised to "Strong-Buy" at Wall Street Zen - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

MiMedx Group (NASDAQ:MDXG) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

Will a bounce in MiMedx Group Inc. offer an exitJuly 2025 Price Swings & Breakout Confirmation Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

MiMedx Group (NASDAQ:MDXG) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Northland Capmk Forecasts Stronger Earnings for MiMedx Group - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Why MiMedx Group Inc. stock appeals to dividend seekersWeekly Investment Summary & Real-Time Market Sentiment Reports - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will MiMedx Group Inc. stock outperform growth indexesPortfolio Risk Summary & Daily Entry Point Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will MiMedx Group Inc. stock go up soonTrend Reversal & Accurate Intraday Trade Tips - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

MiMedx Group (NASDAQ:MDXG) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG), TransMedics Group (TMDX) and Arcus Biosciences (RCUS) - The Globe and Mail

Oct 31, 2025
pulisher
Oct 31, 2025

Is MiMedx Group Inc. stock a buy for dividend growth2025 Volume Leaders & Expert Curated Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using data models to predict MiMedx Group Inc. stock movementSwing Trade & Community Verified Trade Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will MiMedx Group Inc. stock reach Wall Street targetsMarket Activity Report & Daily Profit Focused Stock Screening - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

MiMedx Group Reports Strong Q3 2025 Financial Results - The Globe and Mail

Oct 31, 2025
pulisher
Oct 31, 2025

Is MiMedx Group Inc. stock attractive for ETFsGap Down & Stepwise Trade Signal Implementation - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

MiMedx Group (MDXG): Margin Decline Challenges Bullish Narratives Despite Strong Earnings Growth - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

MiMedx Group Inc. Reports Record Q3 Revenue - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

MiMedx Group (NASDAQ:MDXG) Releases Earnings Results, Beats Expectations By $0.08 EPS - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

MiMedx Group Inc (MDXG) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada

Oct 30, 2025
pulisher
Oct 30, 2025

MiMedx Group Reports Record Q3 2025 Revenue Growth - The Globe and Mail

Oct 30, 2025
pulisher
Oct 30, 2025

MiMedx Group Inc (MDXG) Q3 2025 Earnings Call Highlights: Record - GuruFocus

Oct 30, 2025
pulisher
Oct 30, 2025

MiMedx (MDXG) Q3 2025 Earnings Call Transcript - AOL.com

Oct 30, 2025
pulisher
Oct 30, 2025

MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2025 Earnings Call Transcript - Insider Monkey

Oct 30, 2025
pulisher
Oct 30, 2025

Institutional investors are MiMedx Group, Inc.'s (NASDAQ:MDXG) biggest bettors and were rewarded after last week's US$70m market cap gain - simplywall.st

Oct 30, 2025
pulisher
Oct 30, 2025

Decoding MiMedx Group Inc (MDXG): A Strategic SWOT Insight - GuruFocus

Oct 30, 2025
pulisher
Oct 29, 2025

What indicators show strength in MiMedx Group Inc.2025 Volatility Report & Intraday High Probability Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

MiMedx: Q3 Earnings Snapshot - Chron

Oct 29, 2025
pulisher
Oct 29, 2025

MiMedx raises 2025 revenue growth outlook to mid- to high teens as company posts record quarterly sales - MSN

Oct 29, 2025
pulisher
Oct 29, 2025

MIMEDX (MDXG) Anticipates Strong Future with Strategic Adaptatio - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Transcript : MiMedx Group, Inc., Q3 2025 Earnings Call, Oct 29, 2025 - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

MiMedx Group Inc (MDXG) Q3 2025 Earnings: EPS of $0.15 Beats Est - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

MiMedx Q3 2025 Earnings: $16.7M Net Income, $113.7M RevenueNews and Statistics - IndexBox

Oct 29, 2025
pulisher
Oct 29, 2025

MiMedx Group Inc. Profit Advances In Q3 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Earnings Flash (MDXG) MiMedx Group, Inc. Reports Q3 Revenue $113.7M, vs. FactSet Est of $94.7M - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

MIMEDX Announces Record Revenue for Third Quarter 2025 - The Manila Times

Oct 29, 2025
pulisher
Oct 29, 2025

MiMedx Q3 net sales beat estimates - TradingView

Oct 29, 2025
pulisher
Oct 29, 2025

Earnings Flash (MDXG) MiMedx Group, Inc. Posts Q3 Adjusted EPS $0.15 per Share, vs. FactSet Est of $0.06 - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

MiMedx updates Q3 2025 results with exhibits 99.1–99.3 - Stock Titan

Oct 29, 2025
pulisher
Oct 29, 2025

MDXG Q3 2025: Revenue up 35%, net income $16.7M - Stock Titan

Oct 29, 2025
pulisher
Oct 28, 2025

Is MiMedx Group Inc. stock a defensive play in 2025Quarterly Trade Review & Consistent Income Trade Recommendations - Fundação Cultural do Pará

Oct 28, 2025

Mimedx Group Inc Stock (MDXG) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Cap:     |  Volume (24h):